SecBot SecBot
144 ·Filed Nov 9, 2026

TEVA

TEVA PHARMACEUTICAL INDUSTRIES LTD
NEUTRAL
Impact 2/10
Horizondays Processed7d 7h ago SEC0001973379-26-000365
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

This is a routine insider sale tied to option exercise and compensation, not a strategic exit. Monitor for any pattern of larger insider sales or changes in executive holdings in future Form 4 filings.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1
Entry
$42.40
T+0 close · Nov 9, 2026 · via day close
Latest settled
+1.98%
T+1 · $43.24
Vs SPY
+0.66%
α at T+1
Next horizon
T+5
in 8h
  1. T+0 · Nov 10 $42.40entry
  2. T+1 · 6d ago +1.98%α +0.66% · $43.24
  3. T+4 · todayOpen
  4. T+5 · in 8h Pending
  5. T+20 · in 22d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Richard Daniell, Executive VP European Commercial at Teva, filed a Form 144 notice of intent to sell 25,000 ordinary shares with an approximate market value of $1,072,789. The sale is tied to a stock option exercise and compensation, with the proposed sale date of November 9, 2026. This is a routine insider sale by a senior executive, not the CEO or CFO, and represents a small fraction of the company's $48.7B market cap.

Key Facts

  • Insider Richard Daniell (Executive VP European Commercial) filed Form 144 to sell 25,000 ordinary shares
  • Approximate sale value: $1,072,789.40 based on indicative market price of $42.911576 per share
  • Sale is related to a stock option exercise and compensation
  • Proposed sale date: November 9, 2026
  • Broker: Citigroup Global Markets Inc.
  • Shares to be sold represent about 0.002% of Teva's $48.7B market cap

Financial Impact

Sale of 25,000 shares valued at approximately $1.07M, a small fraction of the insider's likely holdings and negligible relative to Teva's market cap

dilution

Risk Factors

  • Insider sale may signal reduced conviction, though the amount is small relative to total holdings
  • Form 144 is an intent to sell; the actual sale may not occur

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001973379-26-000365
Document: 0001973379-26-000365-index.html0001973379-26-000365
Document: 0001973379-26-000365.txt0001973379-26-000365

Track record

61 reports on TEVA

Performance horizon

6 of 8 bullish or bearish reports moved the stock their way by T+60. Best: +33.06% at T+60 after the Jul 20, 2026 report. 15 of 17 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $43.16 Now $42.57 −1.37% settles Feb 12
  2. Nov 12, 20264d ago 3 Neutral 2/10 Entry $44.50 Now $42.57 −4.34% settles Feb 11
  3. Nov 12, 20264d ago 144 Neutral 2/10 Entry $44.50 Now $42.57 −4.34% settles Feb 11
  4. Nov 12, 20264d ago 144 Neutral 2/10 Entry $43.65 Now $42.57 −2.47% settles Feb 10
  5. Nov 10, 20266d ago 144 Neutral 3/10 Entry $43.24 Now $42.57 −1.55% settles Feb 9
  6. Nov 10, 20266d ago SC 13G/A Neutral 3/10 Entry $42.40 Now $42.57 +0.40% settles Feb 8
  7. Nov 9, 20267d ago 144 Neutral 2/10 Viewing Entry $42.40 Now $42.57 +0.40% settles Feb 8
  8. Nov 6, 202610d ago Insider Cluster Neutral 3/10 Entry $42.97 Now $42.57 −0.93% settles Feb 5
  9. Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $42.97 Now $42.57 −0.93% settles Feb 5
  10. Nov 5, 202611d ago 144 Neutral 2/10 Entry $42.61 Now $42.57 −0.09% settles Feb 4
Showing 10 of 61

US Market Status

Market Closed · Opens Wed (10h 24m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 9, 2026